Our Services
Medical Information
Helpful Resources
Published on: 9/15/2026
Ferrous bisglycinate (chelated iron) is generally the gentlest option, with studies showing fewer reports of constipation, nausea, and bloating than ferrous sulfate, while alternatives like iron polysaccharide complex, heme iron polypeptide, liposomal iron, and lower-dose ferrous gluconate are also better tolerated by many people. Dose and schedule matter as much as the form, since taking a smaller elemental iron dose or dosing every other day can improve absorption and reduce gut side effects. Absorption rates, elemental iron content, cost, and whether you take it with food or vitamin C all change how well a supplement works and how your stomach handles it, so the "gentlest" choice is not the same for everyone. There are several important factors to weigh before switching products, and the complete answer below explains them.
If constipation, fatigue, or stomach upset is pushing you to change supplements, it is worth confirming that low iron is truly what is going on, because similar symptoms can come from thyroid issues, B12 deficiency, IBS, medication effects, or bleeding that needs attention. A free, instant, online symptom check takes just a few minutes, helps you understand what your combination of symptoms may point to, and gives you clear, personalized guidance on whether to adjust your routine or talk with a clinician next.
Last reviewed for medical accuracy: 09/15/2025
Which type of iron supplement is least likely to cause constipation?
Constipation after iron supplements is a common concern. While iron is essential for making hemoglobin and preventing or treating iron-deficiency anemia, some forms of oral iron can slow your digestive tract, leading to uncomfortable bloating, hard stools and constipation. Understanding which type of iron is gentler on your gut can help you meet your iron needs without upsetting your bowels.
When you take iron orally, unabsorbed iron remains in the intestines. This free iron can:
The degree of these effects varies by the chemical form of iron, its dose, and how it’s released in your gut.
Below is an overview of widely used oral iron preparations and their typical side-effect profiles:
• Ferrous sulfate
– The most prescribed form
– High elemental iron content (20% by weight)
– More likely to cause constipation and gastrointestinal upset
• Ferrous fumarate
– Similar elemental iron (33%)
– Slightly better tolerated than ferrous sulfate but still carries a risk
• Ferrous gluconate
– Lower elemental iron (12%)
– Milder on the gut but requires a higher dose to meet iron needs
• Iron polysaccharide complex
– Encapsulated iron molecules
– Released more slowly, reducing mucosal irritation
– Generally less constipating than ferrous salts
• Iron bisglycinate (ferrous bisglycinate chelate)
– Iron bound to two glycine molecules
– Better absorption and fewer side effects
– Much lower rates of constipation
• Ferric maltol
– Newer form with iron bound to maltol
– Designed to improve absorption and tolerance
– Clinical trials show less gastrointestinal distress
• Heme iron polypeptide
– Derived from animal hemoglobin
– More similar to dietary heme iron (red meat)
– Rarely causes constipation, but often costlier
If constipation after iron supplements is your main concern, studies and clinical experience point to the following as the best-tolerated options:
Iron bisglycinate (ferrous bisglycinate chelate)
• Highly bioavailable—more iron absorbed per milligram taken
• Minimal free iron in the gut to cause irritation
• Fewer reports of constipation, nausea and cramps
Iron polysaccharide complex
• Encapsulation shields the gut lining
• Slower, steadier iron release cuts down on side effects
• A good “next step” if bisglycinate isn’t available or affordable
Ferric maltol
• Even release of iron, with very low rates of constipation in trials
• Often prescribed when traditional ferrous salts cause too much GI upset
Heme iron polypeptide
• Very tolerable for most people
• Dose flexibility—less total iron needed, fewer gut side effects
• Typically more expensive and may require a doctor’s prescription
By binding iron to other molecules or using encapsulation, these supplements:
Even if you choose a gentle iron form, adding these habits can further protect you from constipation:
• Take iron with a small snack
– Food can buffer your stomach and intestines
– Avoid high-calcium foods (dairy) at the same time, as they can interfere with iron absorption
• Stay well hydrated
– Aim for 8–10 cups of water daily
– Adequate fluid softens stools and promotes regularity
• Boost dietary fiber
– Include vegetables, fruits, beans and whole grains
– A gradual increase in fiber avoids bloating
• Spread doses or use alternate-day dosing
– Lower daily iron doses (e.g., 60–120 mg elemental iron every other day) improve absorption and reduce side effects
– Some people find a single daily dose easier on their bowels than two or three divided doses
• Consider a stool softener or mild laxative
– Short-term use of polyethylene glycol (Miralax) or docusate sodium (Colace) can help
– Check with your doctor before combining medications
• Monitor your response
– Keep a simple diary of your iron dose, form and any GI symptoms
– Adjust based on tolerance and blood-work results
Most constipation after iron supplements is mild and can be managed with the strategies above. However, talk with a healthcare professional if you experience:
If you’re ever unsure whether your symptoms might be serious, you can try a free, online symptom check, using the doctor approved Ubie Symptom Checker (https://ubiehealth.com/). This tool can help you decide if you need urgent medical attention or a routine follow-up.
Constipation after iron supplements can often be prevented by choosing a gentle iron formulation—such as iron bisglycinate, iron polysaccharide complex, ferric maltol or heme iron polypeptide—and following simple lifestyle and dosing strategies. If symptoms persist or worsen, be sure to speak to a doctor about the best approach for your individual situation, especially if you have any life-threatening or serious concerns.
(References)
* Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, Sekijima Y, Nakamura K. Hereditary Transthyretin Amyloidosis. 1993. PMID: 20301373.
* Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. JAMA. 2015 Mar 3;313(9):949-58. doi: 10.1001/jama.2015.0954. PMID: 25734736.
* Low MS, Speedy J, Styles CE, De-Regil LM, Pasricha SR. Daily iron supplementation for improving anaemia, iron status and health in menstruating women. Cochrane Database Syst Rev. 2016 Apr 18;4(4):CD009747. doi: 10.1002/14651858.CD009747.pub2. Epub 2016 Apr 18. PMID: 27087396; PMCID: PMC10182438.
* Taylor CM, Emmett PM. Picky eating in children: causes and consequences. Proc Nutr Soc. 2019 May;78(2):161-169. doi: 10.1017/S0029665118002586. Epub 2018 Nov 5. PMID: 30392488; PMCID: PMC6398579.
* Rebelo F, Mansur IR, Miglioli TC, Meio MDB, Junior SCG. Dietary and nutritional interventions in children with cerebral palsy: A systematic literature review. PLoS One. 2022;17(7):e0271993. doi: 10.1371/journal.pone.0271993. Epub 2022 Jul 22. PMID: 35867728; PMCID: PMC9307182.
* Lo JO, Benson AE, Martens KL, Hedges MA, McMurry HS, DeLoughery T, Aslan JE, Shatzel JJ. The role of oral iron in the treatment of adults with iron deficiency. Eur J Haematol. 2023 Feb;110(2):123-130. doi: 10.1111/ejh.13892. Epub 2022 Nov 20. PMID: 36336470; PMCID: PMC9949769.
* Ahmad A, Kumar M, Bhoi NR, Badruddeen, Akhtar J, Khan MI, Ajmal M, Ahmad M. Diagnosis and management of uterine fibroids: current trends and future strategies. J Basic Clin Physiol Pharmacol. 2023 May 1;34(3):291-310. doi: 10.1515/jbcpp-2022-0219. Epub 2023 Mar 30. PMID: 36989026.
* Al-Samkari H, Kasthuri RS, Iyer VN, Pishko AM, Decker JE, Weiss CR, Whitehead KJ, Conrad MB, Zumberg MS, Zhou JY, Parambil J, Marsh D, Clancy M, Bradley L, Wisniewski L, Carper BA, Thomas SM, McCrae KR. Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia. N Engl J Med. 2024 Sep 19;391(11):1015-1027. doi: 10.1056/NEJMoa2312749. PMID: 39292928; PMCID: PMC11412318.
* Guardiola-Arévalo A, Mascort Roca J, Noguerol Álvarez M, Carrillo Muñoz R, Mendive Arbeloa JM, Amador Romero J. [Small intestine bacterial overgrowth: Myths and realities]. Aten Primaria. 2025 Apr;57(4):103201. doi: 10.1016/j.aprim.2024.103201. Epub 2025 Jan 11. PMID: 39799751; PMCID: PMC11770485.
* Steinbicker AU, Pantopoulos K. Oral and Intravenous Iron Therapy. Adv Exp Med Biol. 2025;1480:371-386. doi: 10.1007/978-3-031-92033-2_24. PMID: 40603803.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.